Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for steroid-induced hyperglycaemia
ACTRN12620000745943Phase 4Not yet recruiting
- Sponsor
- Gosford Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of empagliflozin in hyperglycemia, sponsored by Gosford Hospital. Primary endpoint: Average time spent within target blood glucose range. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ACTRN12620000745943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000745943.